東凌國際(000893.SZ):中信銀行同意向公司提供1800萬美元的授信額度
格隆匯 8 月 5日丨東凌國際(000893.SZ)公佈,近日,公司與中信銀行股份有限公司廣州分行(“中信銀行”)簽訂《綜合授信合同》,合同約定中信銀行同意向公司提供美元1800萬的授信額度。
該授信由公司下屬控股公司SINO-AGRI POTASH CO., LTD(中農鉀肥有限公司,“中農鉀肥”)提供連帶責任保證擔保,授信用於中農鉀肥日常經營週轉。
公司取得該項授信額度,是金融機構對公司業務和發展前景的認可,為公司老撾鉀鹽項目產能擴建提供了積極的資金保障,有利於進一步改善、提升公司經營業績,符合公司和全體股東的利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.